NIR Light-Activated Nanoparticles for Drug and Gene Delivery
用于药物和基因递送的近红外光激活纳米颗粒
基本信息
- 批准号:8323705
- 负责人:
- 金额:$ 22.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-15 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibodiesBasic ScienceBenignBiocompatibleBiologicalBiological ProcessBypassCaenorhabditis elegansCaliberCancer BiologyCell Culture TechniquesCell LineCellsChemicalsChemistryCombination Drug TherapyComplexCultured CellsCytosolDNADevelopmentDrug ControlsDrug Delivery SystemsEndosomesEpithelial CellsExposure toGene DeliveryGene SilencingGenesGenetic MaterialsGoalsGoldHealthHeatingHela CellsImageLabelLifeLigandsLightLinkLipidsLipofectamineLiposomesMalignant neoplasm of prostateMammalian CellMasksMethodsMicroRNAsMicrobubblesMolecularMusOligonucleotidesOpticsOrganismPatternPharmaceutical PreparationsPhysiologic pulsePolymersPropertyProteinsRNA InterferenceResolutionRouteRuptureSignal Transduction PathwaySilverSiteSmall Interfering RNASourceStructureSulfhydryl CompoundsSurfaceSuspension substanceSuspensionsTechniquesTherapeuticThickTimeTissuesToxic effectTransfectionWaterWorkabsorptionbasecell injurycell typechemical propertychemotherapycontrolled releasedesigndithiolhuman embryonic stem cellhuman stem cellsin vivoirradiationlithographymillisecondnanomaterialsnanoparticlenanorodnanoscalenanoshellnovelphysical propertyreceptorresearch studysmall moleculestem cell differentiationtargeted deliveryvapor
项目摘要
DESCRIPTION (provided by applicant): Our goal is to develop robust siRNA and micro-RNA methods to regulate genes for basic research, permitting both temporal and spatial control of transfection with high efficiency in both cell culture and C. elegans by using the unique chemical and physical properties of hollow gold nanoshells (HGN). HGNs are 30 - 40 nm diameter, 3-5 nm thick, gold shells designed to strongly absorb physiologically friendly NIR light and convert this light energy into local heating. HGN can be easily conjugated to small molecules, targeting ligands, polymers, siRNA and DNA by simple thiol chemistry, or incorporated into or tethered to liposomes. Water, proteins, lipids, etc. do not absorb NIR light, so cells in culture are essentially transparent, which eliminates damage during exposure. Femtosecond NIR light pulses trigger release of thiol-conjugated siRNA or other molecules from the HGN by breaking thiol bonds without damaging the siRNA. Even more important to the development of efficient oligonucleotide and small molecule delivery, the well-known bottleneck of endosomal escape can be bypassed by converting the physiologically friendly NIR light energy absorbed by the HGN to heat, creating unstable microbubbles that mechanically rupture endosomes and release siRNA to the cytosol within seconds. This allows much lower concentrations of HGN-siRNA conjugates to be used, greatly increases transfection efficiency, and provides spatially and temporally controlled transfection that can be used to pattern cultured cells and address specific structures within C. elegans. HGN transfection is as efficient as Lipofectamine, but is non-toxic, and can be used in living organisms. In this proposal, we will use the HGN-siRNA platform to develop masking and unmasking techniques for activating or inactivating biological processes with remote control to devise simple and scalable methods of lithographic patterning of cultured cells in real time. We will investigate controlled release of small molecules from liposomes incorporating HGN using NIR light triggering to control release, thereby enabling basic cell biological studies, including human stem cell differentiation, cancer biology, and signal transduction pathways and routes to applications in chemotherapy and drug delivery. We will develop methods to multiplex the release from a single HGN using a combination of thiol and dithiol anchors that desorbs at different energies to release of multiple chemical species. New silver nanoshells and gold and silver nanorods will be synthesized to probe other regions of the NIR spectrum and provide simultaneous delivery and imaging opportunities. These new constructs could be addressed independently by using different wavelength NIR irradiation. This project takes full advantage of the unique HGN interactions with physiologically friendly NIR light to initiate and control biological processes with precise spatial control at millisecond rates in living cells and organisms.
描述(由申请人提供):我们的目标是开发强大的siRNA和微rna方法来调节基因用于基础研究,利用中空金纳米壳(HGN)独特的化学和物理性质,在细胞培养和秀丽隐杆线虫中高效地控制转染的时间和空间。HGNs的直径为30 - 40 nm,厚度为3-5 nm,外壳为金色,旨在强烈吸收生理上友好的近红外光,并将该光能转化为局部加热。HGN可以通过简单的硫醇化学很容易地偶联到小分子上,靶向配体、聚合物、siRNA和DNA,或者结合到脂质体中或拴在脂质体上。水、蛋白质、脂类等不吸收近红外光,因此培养的细胞基本上是透明的,这消除了暴露时的损伤。飞秒近红外光脉冲通过破坏硫醇键而不破坏siRNA,从而触发硫醇共轭siRNA或其他分子从HGN中释放出来。对于高效寡核苷酸和小分子递送的发展更重要的是,众所周知的内体逃逸瓶颈可以通过将HGN吸收的生理友好的近红外光能量转化为热量来绕过,产生不稳定的微泡,这些微泡可以在几秒钟内机械地破坏内体并将siRNA释放到胞质溶胶中。这允许使用更低浓度的HGN-siRNA偶联物,大大提高转染效率,并提供空间和时间控制的转染,可用于培养细胞和处理秀丽隐杆线虫内的特定结构。HGN转染与Lipofectamine一样有效,但无毒,可用于生物体。在本提案中,我们将使用HGN-siRNA平台开发掩膜和揭膜技术,用于远程控制激活或灭活生物过程,以设计简单且可扩展的方法,实时对培养细胞进行光刻图图化。我们将研究含HGN的脂质体的小分子控制释放,使用近红外光触发来控制释放,从而实现基本的细胞生物学研究,包括人类干细胞分化,癌症生物学,信号转导途径和化疗和药物输送的应用途径。我们将开发一种方法,利用硫醇和二硫醇锚点的组合,以不同的能量解吸以释放多种化学物质,从单个HGN中多重释放。新的银纳米壳和金、银纳米棒将被合成,以探测近红外光谱的其他区域,并提供同步传输和成像的机会。这些新的结构可以通过使用不同波长的近红外辐射来独立地处理。该项目充分利用独特的HGN与生理友好的近红外光相互作用,在活细胞和生物体中以毫秒级的精确空间控制启动和控制生物过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Anthony Zasadzinski其他文献
Joseph Anthony Zasadzinski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Anthony Zasadzinski', 18)}}的其他基金
NIR Light-Activated Nanoparticles for Drug and Gene Delivery
用于药物和基因递送的近红外光激活纳米颗粒
- 批准号:
8390417 - 财政年份:2011
- 资助金额:
$ 22.87万 - 项目类别:
NIR Light-Activated Nanoparticles for Drug and Gene Delivery
用于药物和基因递送的近红外光激活纳米颗粒
- 批准号:
8225217 - 财政年份:2011
- 资助金额:
$ 22.87万 - 项目类别:
NIR Light-Activated Nanoparticles for Drug and Gene Delivery
用于药物和基因递送的近红外光激活纳米颗粒
- 批准号:
8586238 - 财政年份:2011
- 资助金额:
$ 22.87万 - 项目类别:
NIR Light-Activated Nanoparticles for Drug and Gene Delivery
用于药物和基因递送的近红外光激活纳米颗粒
- 批准号:
8027621 - 财政年份:2011
- 资助金额:
$ 22.87万 - 项目类别:
THE 8TH INT CONFERENCE ON ORGANIZED MOLECULAR FILMS
第八届国际有序分子薄膜会议
- 批准号:
2372892 - 财政年份:1997
- 资助金额:
$ 22.87万 - 项目类别:
LIPID AND PROTEIN EFFECTS ON MONOLAYER STABILITY
脂质和蛋白质对单层稳定性的影响
- 批准号:
6490551 - 财政年份:1994
- 资助金额:
$ 22.87万 - 项目类别:
Lipid and Protein Effects on Monolayer Stability
脂质和蛋白质对单层稳定性的影响
- 批准号:
8526491 - 财政年份:1994
- 资助金额:
$ 22.87万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 22.87万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 22.87万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 22.87万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 22.87万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 22.87万 - 项目类别: